Articles

Latest California Healthline Stories

Trump’s Team Cited Safety in Limiting Covid Shots. Patients, Health Advocates See More Risk.

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.

Call Centers Replaced Many Doctors’ Receptionists. Now, AI Is Coming for Call Centers.

Artificial intelligence products with lifelike voices are being marketed to schedule or cancel medical visits, refill prescriptions, and help triage patients. Soon, many patients might initiate contact with the health system by speaking not with a human but with AI.

3 Things To Watch on Mental Health in Trump’s Early Budget Proposals

President Donald Trump’s budget office says he’ll continue to fund the new 988 suicide prevention hotline, but documents sent to Congress offer clues — amid some mixed messages — about the administration’s approach to two pressing public health issues: mental health and addiction.

Trump Won’t Force Medicaid To Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.

Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.

Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions

According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.

Trump’s DOJ Accuses Medicare Advantage Insurers of Paying ‘Kickbacks’ for Primo Customers

The Department of Justice alleges that several major health insurers paid brokerages “hundreds of millions of dollars in kickbacks” to get agents to steer consumers into their Medicare Advantage plans, allegations the insurers strongly dispute.